Delos Reyes, Marivel .
HRN: 11-26-93 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/11/2023
CO-AMOXICLAV 625MG (TAB)
03/11/2023
03/18/2023
PO
625mg
BID
2 Degree RMLE
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes